Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Express Scripts
US Department of Justice
Johnson and Johnson

Generated: June 28, 2017

DrugPatentWatch Database Preview

NITROSTAT Drug Profile

« Back to Dashboard

What is the patent landscape for Nitrostat, and when can generic versions of Nitrostat launch?

Nitrostat is a drug marketed by Pfizer Pharms and Parke Davis and is included in five NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has thirteen patent family members in fifteen countries.

The generic ingredient in NITROSTAT is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

Summary for Tradename: NITROSTAT

Suppliers / Packagers: see list10
Bulk Api Vendors: see list16
Patent Applications: see list2,292
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITROSTAT at DailyMed

Pharmacology for Tradename: NITROSTAT

Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Pharms
TABLET;SUBLINGUAL021134-001May 1, 2000ABRXYesNo6,500,456► Subscribe ► Subscribe
Parke Davis
INJECTABLE;INJECTION018588-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Parke Davis
INJECTABLE;INJECTION070863-001Jan 8, 1987DISCNNoNo► Subscribe► Subscribe
Parke Davis
INJECTABLE;INJECTION018588-002Dec 23, 1983DISCNNoNo► Subscribe► Subscribe
Pfizer Pharms
TABLET;SUBLINGUAL021134-002May 1, 2000ABRXYesNo6,500,456► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: NITROSTAT

Drugname Dosage Strength RLD Submissiondate
nitroglycerinSublingual Tablets0.6 mgNitrostat12/29/2011
nitroglycerinSublingual Tablets0.3 mg, 0.4 mg and 0.6 mgNitrostat10/19/2005

International Patent Family for Tradename: NITROSTAT

Country Document Number Estimated Expiration
Slovenia1019039► Subscribe
New Zealand502878► Subscribe
Australia9489398► Subscribe
Spain2169558► Subscribe
European Patent Office1019039► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Farmers Insurance
Express Scripts
Fish and Richardson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus